David Garber

Dr. David Garber

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MCMichelle Carnazza
Michelle Carnazza
DQDanielle Quaranto
Danielle Quaranto
NDNicole R. DeSouza
Nicole R. DeSouza
AAAugustine A_moscatello
Augustine A_moscatello
DGDavid Garber
David Garber
JGJan Geliebter
Jan Geliebter
The thyroid is a vital endocrine organ that regulates metabolism, heart rate, respiration, digestion, body temperature, brain development, skin and bone maintenance, and reproduction and fertility. Thyroid cancer (TC) is the most common endocrine malignancy, with an estimate of 44,020 new cases in 2025. Incidence has been increasing, most notably at 4–5% per year in young adults. Papillary thyroid cancer (PTC), the most common TC subtype, accounts for approximately 80% of newly diagnosed TC cases. Furthermore, 2290 deaths are expected from the disease in 2025, with survival at over 98% with treatment. However, as PTC occurs most frequently in young women, recurrences are frequent and the 10-year disease-specific survival rate for advanced PTC is less than 50%. This narrative review aims to describe the current understanding of the thyroid gland, the incidence and subtypes of thyroid cancer, and specifically the diagnosis, prognosis, treatment, and recurrence of PTC. This is supplemented by the role of molecular pathways and biomarkers in PTC.

2 November 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DGDavid Garber
David Garber
GWGrace M. Wandell
Grace M. Wandell
TGTheodore A. Gobillot
Theodore A. Gobillot
AMAl Merati
Al Merati
NBNeel K. Bhatt
Neel K. Bhatt
JGJohn Paul Giliberto
John Paul Giliberto

Verified
Journal Article
Open access
PDF file
ACAnthony Centone
Anthony Centone
NDNicole R. DeSouza
Nicole R. DeSouza
NYNang Yang
Nang Yang
SDShaun Desai
Shaun Desai
AMAugustine Moscatello
Augustine Moscatello
XLXiu-min Li
Xiu-min Li
Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive follicular cell-derived malignancy characterized by rapid progression, profound dedifferentiation, and marked resistance to conventional therapy. Despite frequent involvement of major oncogenic pathways, ATC does not exhibit a universal driver mutation, suggesting that its pathogenesis reflects convergence upon shared biological hallmarks rather than dependence on a single molecular event. This review describes the principal mechanistic programs that define the ATC phenotype: disruption of cell-cycle and apoptotic control through alterations in TP53, CDKN2A/B, and aberrant MAPK activation; metabolic adaptations involving glycolysis, glutaminolysis, and mitochondrial one-carbon metabolism; reprogramming of canonical stress response pathways including ER stress and hypoxia signaling; and dynamic remodeling of the tumor microenvironment through cytokine-driven paracrine networks and immune modulation. Collectively, these processes cooperate to generate a highly proliferative, stress-tolerant, immune-inflamed yet immunosuppressed tumor state. A mechanistic understanding of these convergent pathways is essential for rational therapeutic development and for overcoming the profound clinical resistance that defines ATC.

10 May 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
TGTheodore A. Gobillot
Theodore A. Gobillot
DGDavid Garber
David Garber
AMAlbert L. Merati
Albert L. Merati
GWGrace M. Wandell
Grace M. Wandell

15 August 2026 in Journal of Voice
Verified
Journal Article
Closed access
SMStefanie M. Miller
Stefanie M. Miller
AAAbdullah M. Alanazi
Abdullah M. Alanazi
HBHayley L. Born
Hayley L. Born
DGDavid Garber
David Garber
SRSarah K. Rapoport
Sarah K. Rapoport
YBYael Bensoussan
Yael Bensoussan